TICKETS FOR THE NBA CHINA GAMES 2026 PRESENTED BY TAOBAO 88VIP FEATURING THE DALLAS MAVERICKS AND HOUSTON ROCKETS TO GO ON SALE ON AUG. 12

TICKETS FOR THE NBA CHINA GAMES 2026 PRESENTED BY TAOBAO 88VIP FEATURING THE DALLAS MAVERICKS AND HOUSTON ROCKETS TO GO ON SALE ON AUG. 12

– Mavericks and Rockets Will Play Preseason Games on Oct. 9 and 11 at The Venetian Arena in Macao – – Star-Studded Lineup of Artists from Across Asia to Perform at Games and NBA Fan Day – MACAO, Aug. 10, 2026 /PRNewswire/ -- The National Basketball...

Merach Redefines Home Fitness with UltraWalk W60: A 400lb Heavy-Duty, 12% Auto-Incline Walking Pad Built to Last

Merach Redefines Home Fitness with UltraWalk W60: A 400lb Heavy-Duty, 12% Auto-Incline Walking Pad Built to Last

Designed to bridge the gap between compact convenience and professional durability, the UltraWalk W60 Plus offers "treadmill-level" experience, elimination of jolting movements and lag, with immersive features, in a space-saving design, at an...

Prepare for a Healthier Holiday Season with Wellness Tips from VARON Oxygen Concentrators

Prepare for a Healthier Holiday Season with Wellness Tips from VARON Oxygen Concentrators

MANILA, Philippines , Dec. 19, 2025 /PRNewswire/ -- As the holiday season begins to unfold in the Philippines, families are starting to plan gatherings, reunions, and early celebrations. For households with elderly relatives or loved ones managing...

Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis

Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis

HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the National...

menu
menu